Abstract
Exercise represents a physical stress that challenges homeostasis. In response to
this stressor, the autonomic nervous system and hypothalamus-pituitary-adrenal axis
are known to react and participate in the maintenance of homeostasis and the development
of physical fitness. This includes elevation of cortisol and catecholamines in plasma.
However, physical conditioning is associated with a reduction in pituitary-adrenal
activation in response to exercise. On the other hand, highly trained athletes exhibit
chronic mild hypercortisolism at baseline that may be an adaptive change to chronic
exercise. In addition the proinflammatory cytokine, IL-6 is also activated, probably
via catecholamines. On the other hand, the stress of chronic exercise induces certain
changes to the thyroid axis. Peripheral thyroid hormone metabolism suppression is
observed, and the result is a hormonal status similar to that of euthyroid sick syndrome
(ESS), with suppression of T3 and elevation of rT3 plasma levels. One mechanism proposed involves exercise-activated pathways participating
in the pathogenesis of ESS. This is realized through norepinephrine’s activation of
NF-κB. Neuroendocrine response to exercise stress involves activation of NF-κB resulting
in inactivation of T3 -dependent 5’-deiodinase gene expression and enzyme activity. Thus, ESS is generated
in the periphery. On the other hand, activation and nuclear translocation of NF-κB
leads to increased transcription of proinflammatory genes responsible for the expression
of proinflammatory cytokines such as TNF-α and IL-6. These cytokines could activate
cortisol, which in turn inhibits NF-κB activation through IκB and finally shuts down
this cycle.
Key words
Exercise - HPA axis - Thyroid and stress - Euthyroid sick syndrome
References
1
Chrousos G P.
Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis.
Endocrinol Metab Clin North Am.
1992;
21
833-858
2
Mastorakos G, Ilias I.
Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
Ann. N. Y. Acad.
Sci.
2003;
997
1-14
3
Kamal E H, Gold P W, Chrousos G P.
Neuroendocrinology of stress.
Endocrinol Metab Clin North Am.
2001;
30
695-728
4
Larsen P J, Jessop D, Patel H, Lightman S L, Chowdrey H S.
Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a
central mechanism involving corticotrophin-releasing factor-containing neurons in
the hypoyhalamic paraventricular nucleus.
J Neuroendocrinol.
1993;
5
99-105
5
Chrousos G P.
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.
New Engl J Med.
2004;
332
1351-1362
6
Mastorakos G, Weber J S, Magiakou M A, Gunn H, Chrousos G P.
Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin
secretion by recombinant interleukin-6 in humans: potential implications for the syndrome
of inappropriate vasopressin secretion. J.
Clin Endocrinol..
Metab1994;
79
934-939
7
Mastorakos G, Chrousos G P, Weber J S.
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
J Clin Endocrinol Metab.
1993;
77
1690-1694
8
Crofford L J, Kalogeras K T, Mastorakos G. et al .
Circadian relationships between interleukin-6 (IL-6) and hypothalamic pituitary-adrenal
axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with
early untreated rheumatoid arthritis.
J Clin Endocrinol.
Metab1997;
82
1279-1283
9
Imura H, Fucata J, Mori T.
Cytokines and endocrine functions: an interaction between the immune and neuroendocrine
systems.
Clin Endocrinol.
1991;
35
107-115
10
Kelso T B, Herbert W G, Gwazdauskas F C, Goss F L, Hess J L.
Exercise-thermoregulatory stress and increased plasma β-endorphin/β-lipotropin in
humans. J.
Appl..
Physiol1984;
57
444-449
11
Luger A, Deuster P A, Kyle S B. et al .
Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise.
N Engl J Med.
1987;
316
1309-1315
12
DeRijk R H, Boelen A, Tilders F JH, Berkenbosch F.
1994 Induction of plasma interleukin-6 by circulating adrenaline in the rat.
Psychoneuroendocrinology.
1987;
19
155-163
13
Papanicolaou D A, Petrides J S, Tsigos C. et al .
Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation
with catecholamines.
Endocrinol Metab.
1996;
34
E601-E605
14
Barder A E, Coyle S M, Marano E.
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man.
J.
Immunol.
1999;
150
1999-2006
15
Hogevold H E, Kierulf P, Ovstebo R, Reikeros O.
Acute phase reactants and interleukin6 after total hip replacement; effects of high
dose cortcosteroids.
Eur J Surg.
1992;
158
339-345
16
Terebuh P D, Otterness I G, Strieter R M. et al .
Biologic and immunohistohemichal analysis of interleukin-6 expression in vivo. Constitutive
and induced expression in murine polymorphonuclear and mononuclear phagocytes.
Am J Pathol.
1992;
140
649-657
17 Greenspan F S. The thyroid gland. Basic and Clinical Endocrinology 7th edition. Greenspan
FS, Gardner DG (Ed) Lange/ Mc Graw-Hill 2004 7: 215-294
18 Reichlin S.
Neuroendocrinology. Wilson JD, Foster DW, Krnonenberg HM, Larsen PR Williams Textbook of Endocrinology
9th edition. Philadelphia, PA; W. B Saunders Company 1998 8: 185-187, 203-206
19
Kelly G.
Peripheral metabolism of thyroid hormones: a review.
Altern Med Rev.
2000;
5
306-333
20
Wirth A, Holm G, Lindstedt G, Lundberg P A, Bjorntorp P.
Thyroid hormones and lipolysis in physically trained rats.
Metabolism.
1981;
30
237-241
21
Simsch C, Lormes W, Petersen K G. et al .
Training intensity influences leptin and thyroid hormones in highly trained rowers.
Int J Sports Med.
2002;
23
422-427
22
Krotkiewski M, Sjostrom L, Sullivan L. et al .
The effect of acute and chronic exercise on thyroid hormones in obesity.
Acta Med Scand.
1984;
216
269-275
23
Limanova Z, Sonka J, Kratochvil O. et al .
Effects of exercise on serum cortisol and thyroids hormones.
Exp Clin Endocrinol.
1983;
81
308-314
24
Opstad K.
Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep
and energy deficiency in young men.
Eur J Endocrinol.
1994;
131
56-66
25
O’Connell M, Robbins D C, Horton E S, Sims E A, Danforth E Jr.
Changes in serum concentrations of 3,3’,5’-Triiodothyronine and 3,5,3’-Triiodothyronine
during prolonged moderate exercise.
J Clin Endocrinol.
Metab1979;
49
242-246
26
Loucks A B, Heath E M.
Induction of low-T3 syndrome in exercising women occurs at a threshold of energy availability.
Am J Physiol.
1994;
266
R817-R823
27
Baylor L S, Hackney A C.
Resting thyroid and leptin hormone changes in women following intense, prolonged exercise
training.
Eur J Appl Physiol.
2002;
88
480-484
28
Ghizzoni L, Mastorakos G, Ziveri M. et al .
Interactions of leptin and thyrotropin 24-hour secretory profiles in short normal
children.
J Clin Endocrinol Metab.
2001;
86
2065-2072
29
Bunt J C.
Hormonal alterations due to exercise.
Sports Med.
1986;
3
331-345
30
Thornton J R.
Hormonal responses to exercise and training.
Vet Clin North Am Equine Pract.
1985;
1
477-496
31
Mastorakos G, Pavlatou M, Diamanti-Kandarakis E.
Chrousos GP. Exercise and the stress system.
Hormones.
2005;
4
73-89
32
Chopra I J.
Euthyroid sick syndrome: is it a misnomer?.
The Journal of Clinical Endocrinology and Metabolism.
1997;
82
329-334
33
Fliers E, Alkemade A, Wiersinga W M.
The hypothalamic-pituitary-thyroid axis in critical illness.
Best Practice and Research Clinical Endocrinology and Metabolism.
2001;
15
453-464
34
De Groot J L.
Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome.
Journal of Clinical Endocrinology and Metabolism.
1999;
84
151-164
35
Kaptein E M.
Thyroid hormone metabolism and thyroid diseases in chronic renal failure.
Endocr Rev.
1996;
17
45-63
36
Kaptein E M, Robinson W J, Grieb D A, Nicoloff J T.
Peripheral serum thyroxine, triiodothyronine and reverse triodothyronine kinetics
in the low thyronine state of acute nonthyroidal illnesses.
J Clin Invest.
1982;
69
526-535
37
Huang T S, Wu H P, Huang L S, Lai M Y, Ho S W, Chopra I J.
A study of thyroidal response to thyrotropin (TSH) in decompensated liver cirrhosis.
Thyridology.
1989;
1
137-142
38
Bianco A C, Nunes M T, Hell N S, Maciel R MB.
The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3, 5,
3’-triiodothyronine generation in rats.
Endocrinology.
1987;
120
1033-1038
39
Van den Berghe G, de Zegher F, Bouillon R.
Acute and prolonged critical illness as different neuroendocrine paradigms.
Journal of Clinical Endocrinology and Metabolism.
1998;
83
1827-1834
40
Van der Poll T, Romijin J A, Wiersinga W M, Sauerwein H P.
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome.
J Clin Endocrinol Metab.
1991;
71
1567-1572
41
Chopra I J, Sakane S, Chua T eco.
A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal
illness.
J Clin Endocrinol Metab.
1991;
72
1113-1116
42
Cannon J G, Tompkins R G, Gelfand J A. et al .
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental
endotoxin fever.
J Infect Dis.
1990;
161
79-84
43
Van der Poll T, Van Zee K J, Endert E. et al .
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma
thyroid hormone and thyrotropin concentrations in man.
J Clin Endocrinol Metab.
1995;
80
1341-1346
44
Boelen A, Platvoet-ter S chphorst, Wiersinga W M.
Association between serum intrrleukin-6 and serum 3,5,3’-triiodothyronine in nonthyroidal
illness.
J Clin Endocrinol.
Metab1993;
77
1695-1699
45
Stouthard J M, van der Poll T, Endert E, Bakker P J. et al .
Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism
in humans.
J Clin Endocrinol Metab.
1994;
79
1342-1346
46
Michalaki M, Vagenakis A G, Makri M, Kalfarentzos F, Kyriazopoulou V.
Dissociation of the early decline in serum T3 concetration and serum IL-6 rise and TNFa in nonthyroidal illness syndrome induced
by abdominal surgery.
The Journal of Clinical Endocrinology and Metabolism.
2001;
86
4198-4205
47
Boelen A, Platvoet-ter Schiphorst M C, Wiersinga W M.
Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon
does not prevent the LPS-induced sick euthyroid syndrome in mice.
J Endocrinol.
2001;
153
115-122
48
Pang X P, Hershman J M, Mirell C J, Pekary A E.
Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant
tumor necrosis factor-α (cachectin).
Endocrinology.
1989;
125
76-84
49
Nagaya T, Fujieda M, Otsuka G, Yang J P, Okamoto T, Seo H.
A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome.
J Clin Invest.
2000;
106
393-402
50
Perkins N D.
Regulation of NF-κ B by cyclin-dependent kinases associated with the p300 coactivator.
Science.
1997;
275
523-527
51
Madrigal J L, Hurtado O, Moro M A. et al .
The increase in TNF-α levels is implicated in NF-Kappa B activation inducible nitric
oxide synthase expression in brain cortex after immobilization stress.
Neuropsychopharmagology.
2002;
26
155-163
52
Bierhaus A, Wolf J, Andrassy M, Rohleder N.
A mechanism converting psychosocial stress into mononuclear cell activation.
PNAS.
2003;
100
1920-1925
53
Kirschbaum C, Pirke K M, Hellhammer D H.
The ”Trier Social Stress Test” - a tool for investigating psychobiological stress
responses in a laboratory setting.
Neuropsychobiology.
1993;
28
76-81
54
Karlamangla A S, Singer B H, McEwen B S, Rowe J W, Seeman T E.
Allostatic load as a predictor of functional decline. MacArthur studies of successful
aging.
J Clin Epidemiol.
2002;
55
696-710
55
Aljada A, Ghanim H, Assian E. et al .
1996 Increased IkB expression and diminished nuclear NF-kB in human mononuclear cells
following hydrocortisone injection.
The Journal of Clinical Endocrinology and Metabolism.
2002;
84
3386-3389
56
De Bosscher K, Schmitz M L, Vanden B erghe, Plaisance S, Fiers W, Haegeman G.
Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves
direct interference with transactivation.
Proc Natl Acad Sci USA.
1997;
94
13 504-13 509
57
Auphan N, DiDonato J A, Rosette C, Helmberg A, Karin M.
Immunosuppression by glucocorticoids: inhibition of NF-κ B activity through induction
of I κ B synthesis.
Science.
1995;
270
286-290
58
Farmer P, Pugin J.
Beta-adrenergic agonists exert their ”anti-inflammatory“ effects in monocytic cells
through the I κ B/NF-κ B pathway.
Am J Physiol Lung Cell Mol Physiol.
2000;
279
L675-L682
59
Aksoy M O, Bin W, Yang Y, Yun-You D, Kelsen S G.
Nuclear factor-Kappa B augments β (2)-adrenergic receptor expression in human airway
epithelial cells. Am. J.
Physiol.
2001;
281
L1271-L1278
G. Mastorakos
Endocrine Unit, Second Department of Obstetrics and Gynecology, ARETAIEION Hospital,
Athens Medical School, National Kapodistriakon University of Athens
3, Neofytou Vamva · 10674 · Athens · Greece
Fax: +30 (210) 363 62 29
eMail: mastorak@mail.kapatel.gr